Compare CTS & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTS | PLSE |
|---|---|---|
| Founded | 1896 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2016 |
| Metric | CTS | PLSE |
|---|---|---|
| Price | $44.31 | $14.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | ★ 191.3K | 183.4K |
| Earning Date | 02-03-2026 | 11-05-2025 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | ★ 3.07 | N/A |
| EPS | ★ 1.98 | N/A |
| Revenue | ★ $531,522,000.00 | $86,000.00 |
| Revenue This Year | $5.73 | N/A |
| Revenue Next Year | $4.00 | $1,002.94 |
| P/E Ratio | $22.47 | ★ N/A |
| Revenue Growth | ★ 3.61 | N/A |
| 52 Week Low | $34.02 | $12.56 |
| 52 Week High | $57.49 | $25.00 |
| Indicator | CTS | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 48.18 |
| Support Level | $42.68 | $13.12 |
| Resistance Level | $45.71 | $14.75 |
| Average True Range (ATR) | 1.21 | 0.64 |
| MACD | 0.09 | 0.23 |
| Stochastic Oscillator | 65.27 | 61.94 |
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.